Oxymorphone hydrochloride 7.5 mg/1 (Oxymorphone hydrochloride TABLET, FILM COATED, EXTENDED RELEASE) 7.5 mg/1

Oxymorphone hydrochloride 7.5 mg extended-release tablets provide long-lasting pain relief. This opioid analgesic is designed for around-the-clock management of moderate to severe pain. Learn more about its uses and effects.

Strength

7.5 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)

Manufacturer / TM Owner

Amneal Pharmaceuticals of New York LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxymorphone hydrochloride is an opioid medication primarily used for managing moderate to severe pain. It is often prescribed for conditions requiring extended pain relief, such as chronic pain or post-surgical recovery. The extended-release formulation ensures sustained pain management over an extended period.

Side Effects

Common effects of oxymorphone hydrochloride may include drowsiness, dizziness, and nausea. Some users may experience constipation or dry mouth. These effects can vary depending on individual tolerance and dosage.

Precautions & Warnings

Handle oxymorphone hydrochloride with care, as it is a potent opioid. Always follow the prescribed dosage and avoid activities requiring alertness until you know how the medication affects you. Store in a secure place to prevent misuse.

Avoid Interactions

Oxymorphone hydrochloride may interact with alcohol, other opioids, and certain antidepressants. It can also interact with medications that affect liver enzymes, such as CYP3A4 inhibitors. Always consult a healthcare provider before combining with other treatments.

Frequently Asked Questions

Oxymorphone hydrochloride is used for managing moderate to severe pain, often in conditions requiring extended pain relief.

The extended-release formulation is designed to provide sustained pain relief over an extended period, reducing the need for frequent dosing.

Common side effects may include drowsiness, dizziness, nausea, constipation, and dry mouth.

It may interact with alcohol, other opioids, and certain antidepressants. Always consult a healthcare provider before combining with other treatments.

Store oxymorphone hydrochloride in a secure place at room temperature, away from moisture and heat, to prevent misuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.